Control of fibrinogen biosynthesis: role of the FFA/albumin ratio.
The rate of biosynthesis and turnover of the plasma protein fibrinogen is a marker of metabolic signaling in aging and disease. The rate in the young normal human subject of 0.260 mg/ml/24 h increases to 0.378 in older normal subjects and to 0.466 in age matched coronary thrombosis patients measured by endogenous labeling of fibrinogen with L: -glutamic acid-C14. The increased rate of fibrinogen turnover has been traced to generation of fibrin by labeling the polymers with glycine C14 ethyl esters in the presence of activated fibrin stabilizing factor. Circulating fibrin increased 520% above normal in ischemic thrombotic cerebrovascular disease. Long chain saturated free fatty acids (FFA) exercise not only primary control over incorporation of Cl4 labeled amino acids into the fibrinogen structure but also activate the cascade sequence of reactions which convert fibrinogen into occlusive fibrin polymers. FFA are normally bound and transported by plasma albumin to mitochondrial sites of energy metabolism. Albumin synthesis declines with aging. This decline is associated with increased plasma levels of FFA resulting in an increase in the plasma FFA/albumin ratio. Correction of this ratio in vitro by restoration of a normal FFA/albumin ratio restores a normal level of fibrinogen synthesis by human hepatocytes.
Pilgeram
Laurence
L
Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, CA, USA. eric.farr@springer.com
D000328:Adult; D000368:Aged; D000375:Aging / Q000378:metabolism*; D002478:Cells, Cultured; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005260:Female; D005340:Fibrinogen / Q000096:biosynthesis*; D022781:Hepatocytes / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012709:Serum Albumin / Q000378:metabolism*; D055815:Young Adult
D005230:Fatty Acids, Nonesterified; D012709:Serum Albumin; D005340:Fibrinogen
J Biol Chem. 1960 Sep;235:2595-9
13817286
Naturwissenschaften. 1993 Dec;80(12):547-55
8302368
Circulation. 1991 Mar;83(3):836-44
1999035
Arterioscler Thromb. 1994 Jan;14(1):54-9
8274478
J Pathol Bacteriol. 1946 Apr;58:207-12
20996420
Thromb Diath Haemorrh. 1963 Jul 15;143:346-53
14081258
Lancet. 1986 Sep 6;2(8506):533-7
2875280
J R Coll Gen Pract. 1985 Dec;35(281):565-9
4093900
J Appl Physiol. 1961 Jul;16:660-4
13735726
Thromb Diath Haemorrh. 1968 Nov 15;20(1):31-43
5708898
Arterioscler Thromb Vasc Biol. 1995 Sep;15(9):1263-8
7670937
J Atheroscler Res. 1968 Jan-Feb;8(1):155-66
5642099
Stroke. 1973 Jul-Aug;4(4):643-57
4723694
Arch Biochem Biophys. 1957 Oct;71(2):346-51
13471036
J Gerontol. 1958 Jan;13(1):32-42
13514035
Thromb Diath Haemorrh. 1967 May 31;17(3-4):358-64
5589295
J Clin Invest. 1963 Jun;42:860-6
14022629
Arterioscler Thromb Vasc Biol. 1996 Mar;16(3):351-6
8630658
Naturwissenschaften. 1984 Jul;71(7):372-4
6482979
Arterioscler Thromb Vasc Biol. 1995 Sep;15(9):1269-79
7670938
Am J Pathol. 1963 Dec;43:987-98
14099459
JAMA. 1987 Sep 4;258(9):1183-6
3626001
Eur Heart J. 1992 Feb;13(2):166-70
1313369
J Atheroscler Res. 1964 May-Jun;4:244-53
14181607
Circulation. 1997 Dec 16;96(12):4204-10
9416883
Lancet. 1949 Nov 19;2(6586):925-7
15395606